105 related articles for article (PubMed ID: 35559949)
21. Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer.
Hu X; Lipscomb J; Jiang C; Graetz I
J Natl Cancer Inst; 2023 Mar; 115(3):268-278. PubMed ID: 36583540
[TBL] [Abstract][Full Text] [Related]
22. Early impact of Medicare accountable care organizations on cancer surgery outcomes.
Herrel LA; Norton EC; Hawken SR; Ye Z; Hollenbeck BK; Miller DC
Cancer; 2016 Sep; 122(17):2739-46. PubMed ID: 27218198
[TBL] [Abstract][Full Text] [Related]
23. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
24. Oncologist Support for Consolidated Payments for Cancer Care Management in the United States.
Narayanan S; Hautamaki E
Am Health Drug Benefits; 2016 Jul; 9(5):280-9. PubMed ID: 27625745
[TBL] [Abstract][Full Text] [Related]
25. Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia.
Huang Q; Emond B; Lafeuille MH; Gupta D; Lefebvre P; Sundaram M; Mato A
Curr Med Res Opin; 2020 Dec; 36(12):2009-2018. PubMed ID: 33044848
[TBL] [Abstract][Full Text] [Related]
26. Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.
Muldoon LD; Pelizzari PM; Lang KA; Vandigo J; Pyenson BS
Health Aff (Millwood); 2018 May; 37(5):743-750. PubMed ID: 29733731
[TBL] [Abstract][Full Text] [Related]
27. Secret Sauce-How Diverse Practices Succeed in Centers for Medicare & Medicaid Services Oncology Care Model.
Kline RM; Blau S; Buescher NR; Ellis AR; Hoverman JR; Oyer RA; Wilfong LS; Rocque GB
JCO Oncol Pract; 2021 Dec; 17(12):734-743. PubMed ID: 34406820
[TBL] [Abstract][Full Text] [Related]
28. Medicare Spending after 3 Years of the Medicare Shared Savings Program.
McWilliams JM; Hatfield LA; Landon BE; Hamed P; Chernew ME
N Engl J Med; 2018 Sep; 379(12):1139-1149. PubMed ID: 30183495
[TBL] [Abstract][Full Text] [Related]
29. Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program.
Cole AP; Krasnova A; Ramaswamy A; Fletcher SA; Friedlander DF; McNabb-Baltar J; Melnitchouk N; Lipsitz SR; Sun M; Kibel AS; Golshan M; Haider AH; Weissman JS; Trinh QD
J Oncol Pract; 2019 Jun; 15(6):e547-e559. PubMed ID: 30998420
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Experiences of Patients in the Oncology Care Model.
Franklin EF; Nichols HM; Bohannon L
JCO Oncol Pract; 2020 Dec; 16(12):e1433-e1440. PubMed ID: 33026952
[TBL] [Abstract][Full Text] [Related]
31. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
[TBL] [Abstract][Full Text] [Related]
32. Commentary: Quality nutrition care is integral to the Oncology Care Model.
Arensberg MB; Besecker B; Weldishofer L; Drawert S
Support Care Cancer; 2021 Dec; 29(12):7139-7142. PubMed ID: 34297220
[TBL] [Abstract][Full Text] [Related]
33. Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program.
Schwartz AL; Chernew ME; Landon BE; McWilliams JM
JAMA Intern Med; 2015 Nov; 175(11):1815-25. PubMed ID: 26390323
[TBL] [Abstract][Full Text] [Related]
34. Association of Physician Group Participation in Accountable Care Organizations With Patient Social and Clinical Characteristics.
Werner RM; Kanter GP; Polsky D
JAMA Netw Open; 2019 Jan; 2(1):e187220. PubMed ID: 30657535
[TBL] [Abstract][Full Text] [Related]
35. Interpreting Oncology Care Model Data to Drive Value-Based Care: A Prostate Cancer Analysis.
Ennis RD; Parikh AB; Sanderson M; Liu M; Isola L
J Oncol Pract; 2019 Mar; 15(3):e238-e246. PubMed ID: 30742551
[TBL] [Abstract][Full Text] [Related]
36. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
[TBL] [Abstract][Full Text] [Related]
37. Changes in specialty care use and leakage in Medicare accountable care organizations.
Barnett ML; McWilliams JM
Am J Manag Care; 2018 May; 24(5):e141-e149. PubMed ID: 29851445
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment.
Castellanos EH; Orlando A; Ma X; Parikh RB; O'Connell G; Meropol NJ; Hamrick J; Adamson BJS
JCO Oncol Pract; 2020 Oct; 16(10):e1216-e1221. PubMed ID: 32496874
[TBL] [Abstract][Full Text] [Related]
39. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
[TBL] [Abstract][Full Text] [Related]
40. Estimates of ACO savings in the presence of provider and beneficiary selection.
Ouayogodé MH; Meara E; Ho K; Snyder CM; Colla CH
Healthc (Amst); 2021 Mar; 9(1):100460. PubMed ID: 33412439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
